MSCs modified with ACE2 restore endothelial function following LPS challenge by inhibiting the activation of RAS

Journal of Cellular Physiology

Volumn 230, Issue 3, 2015, Pages 691-701

  He, Hong li ^a   Liu, Ling ^a   Chen, Qi hong ^a   Cai, Shi xia ^a   Han, Ji bin ^a   Hu, Shu ling ^a   Chun, Pan ^a   Yang, Yi ^a   Guo, Feng mei ^a   Huang, Ying zi ^a   Qiu, Hai bo ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ANGIOTENSIN[1-7]; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LENTIVIRUS VECTOR; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN; ANGIOTENSIN I; ANGIOTENSIN I (1-7); DIPEPTIDYL CARBOXYPEPTIDASE; PEPTIDE FRAGMENT;

ACUTE LUNG INJURY; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CAPILLARY ENDOTHELIAL CELL; CELL AGING; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DNA MODIFICATION; DOWN REGULATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MEDIATOR RELEASE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASCULAR ENDOTHELIUM; ANIMAL; CHEMICALLY INDUCED; CYTOLOGY; GENE THERAPY; GENETICS; HEK293 CELL LINE; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; TOXICITY;

ANIMALIA;

ACUTE LUNG INJURY; ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; ENDOTHELIAL CELLS; GENETIC THERAPY; HEK293 CELLS; HUMANS; LIPOPOLYSACCHARIDES; MESENCHYMAL STROMAL CELLS; MICE; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; RENIN-ANGIOTENSIN SYSTEM;

EID: 84920911249     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24794     Document Type: Article

References (44)

1. Bannerman DD, Goldblum SE. 2003. Mechanisms of bacterial lipopolysaccharide-induced endothelial apoptosis. Am J Physiol Lung Cell Mol Physiol 284:L899-L914.
2. Campbell AI, Zhao Y, Sandhu R, Stewart DJ. 2001. Cell-based gene transfer of vascular endothelial growth factor attenuates monocrotaline-induced pulmonary hypertension. Circulation 104:2242-2248.
3. Clarke NE, Turner AJ. 2012. Angiotensin-converting enzyme 2: The first decade. Int J Hypertens 2012:307315.
4. Dandona P, Dhindsa S, Ghanim H, Chaudhuri A. 2007. Angiotensin II and inflammation: The effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade. J Hum Hypertens 21:20-27.
5. Dejana E, Orsenigo F, Lampugnani MG. 2008. The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 121:2115-2122.
6. Feletou M, Vanhoutte PM. 2006. Endothelial dysfunction: A multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol 291:H985-H1002.
7. Hartley JL, Temple GF, Brasch MA. 2000. DNA cloning using in vitro site-specific recombination. Genome Res 10:1788-1795.
8. Hotchkiss RS, Strasser A, McDunn JE, Swanson PE. 2009. Cell death. N Engl JMed 361:1570-1583.
9. Imai Y, Kuba K, Ohto-Nakanishi T, Penninger JM. 2010. Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis. Circ J 74:405-410.
10. Imai Y, Kuba K, Penninger JM. 2007. Angiotensin-converting enzyme 2 in acute respiratory distress syndrome. Cell Mol Life Sci 64:2006-2012.
11. Imai Y, Kuba K, Penninger JM. 2008. The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice. Exp Physiol 93:543-548.
12. Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, Yang P, Sarao R, Wada T, Leong-Poi H, Crackower MA, Fukamizu A, Hui CC, Hein L, Uhlig S, Slutsky AS, Jiang C, Penninger JM. 2005. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436:112-116.
13. Kanki-Horimoto S, Horimoto H, Mieno S, Kishida K, Watanabe F, Furuya E, Katsumata T. 2006. Implantation of mesenchymal stem cells overexpressing endothelial nitric oxide synthase improves right ventricular impairments caused by pulmonary hypertension. Circulation 114:I181-I185.
14. Kim YC, Day RM. 2012. Angiotensin II regulates activation of Bim via Rb/E2F1 during apoptosis: Involvement of interaction between AMPKbeta1/2 and Cdk4. Am J Physiol Lung Cell Mol Physiol 303:L228-L238.
15. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O. 2003. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 31:890-896.
16. Lee JW, Fang X, Krasnodembskaya A, Howard JP, Matthay MA. 2011. Concise review: Mesenchymal stem cells for acute lung injury: role of paracrine soluble factors. Stem Cells 29:913-919.
17. Lee YH, Mungunsukh O, Tutino RL, Marquez AP, Day RM. 2010. Angiotensin-II-induced apoptosis requires regulation of nucleolin and Bcl-xL by SHP-2 in primary lung endothelial cells. J Cell Sci 123:1634-1643.
18. Lin X, Dean DA. 2011. Gene therapy for ALI/ARDS. Crit Care Clin 27:705-718.
19. Liu AR, Liu L, Chen S, Yang Y, Zhao HJ, Liu L, Guo FM, Lu XM, Qiu HB. 2013. Activation of canonical wnt pathway promotes differentiation of mouse bone marrow-derived MSCs into type II alveolar epithelial cells, confers resistance to oxidative stress, and promotes their migration to injured lung tissue in vitro. J Cell Physiol 228:1270-1283.
20. Liu L, Qiu HB, Yang Y, Wang L, Ding HM, Li HP. 2009. Losartan, an antagonist of AT1 receptor for angiotensin II, attenuates lipopolysaccharide-induced acute lung injury in rat. Arch Biochem Biophys 481:131-136.
21. Lund DD, Brooks RM, Faraci FM, Heistad DD. 2007. Role of angiotensin II in endothelial dysfunction induced by lipopolysaccharide in mice. Am J Physiol Heart Circ Physiol 293:H3726-H3731.
22. Maniatis NA, Kotanidou A, Catravas JD, Orfanos SE. 2008. Endothelial pathomechanisms in acute lung injury. Vascul Pharmacol 49:119-133.
23. Matthay MA, Ware LB, Zimmerman GA. 2012. The acute respiratory distress syndrome. J Clin Invest 122:2731-2740.
24. McGinley L, McMahon J, Strappe P, Barry F, Murphy M, O'Toole D, O'Brien T. 2011. Lentiviral vector mediated modification of mesenchymal stem cells & enhanced survival in an in vitro model of ischaemia. Stem cell Res Ther 2:12.
25. Mei SH, McCarter SD, Deng Y, Parker CH, Liles WC, Stewart DJ. 2007. Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med 4:e269.
26. Molthen RC, Wu Q, Fish BL, Moulder JE, Jacobs ER, Medhora MM. 2012. Mitigation of radiation induced pulmonary vascular injury by delayed treatment with captopril. Respirology 17:1261-1268.
27. Morrison DC, Ulevitch RJ. 1978. The effects of bacterial endotoxins on host mediation systems. A review. Am J Pathol 93:526-618.
28. Nemeth K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, Robey PG, Leelahavanichkul K, Koller BH, Brown JM, Hu X, Jelinek I, Star RA, Mezey E. 2009. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15:42-49.
29. Orfanos SE, Mavrommati I, Korovesi I, Roussos C. 2004. Pulmonary endothelium in acute lung injury: from basic science to the critically ill. Intensive care Med 30:1702-1714.
30. Pati S, Gerber MH, Menge TD, Wataha KA, Zhao Y, Baumgartner JA, Zhao J, Letourneau PA, Huby MP, Baer LA, Salsbury JR, Kozar RA, Wade CE, Walker PA, Dash PK, Cox CS, Jr., Doursout MF, Holcomb JB. 2011a. Bone marrow derived mesenchymal stem cells inhibit inflammation and preserve vascular endothelial integrity in the lungs after hemorrhagic shock. PLoS One 6:e25171.
31. Pati S, Khakoo AY, Zhao J, Jimenez F, Gerber MH, Harting M, Redell JB, Grill R, Matsuo Y, Guha S, Cox CS, Reitz MS, Holcomb JB, Dash PK. 2011b. Human mesenchymal stem cells inhibit vascular permeability by modulating vascular endothelial cadherin/beta-catenin signaling. Stem Cells Dev 20:89-101.
32. Pittet JF, Mackersie RC, Martin TR, Matthay MA. 1997. Biological markers of acute lung injury: prognostic and pathogenetic significance. Am J Respir Crit Care Med 155:1187-1205.
33. Rentzsch B, Todiras M, Iliescu R, Popova E, Campos LA, Oliveira ML, Baltatu OC, Santos RA, Bader M. 2008. Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function. Hypertension 52:967-973.
34. Schaller MD, Waeber B, Nussberger J, Brunner HR. 1985. Angiotensin II, vasopressin, and sympathetic activity in conscious rats with endotoxemia. Am J Physiol 249:H1086-H1092.
35. Vandenbroucke E, Mehta D, Minshall R, Malik AB. 2008. Regulation of endothelial junctional permeability. Ann N Y Acad Sci 1123:134-145.
36. Wang HL, Akinci IO, Baker CM, Urich D, Bellmeyer A, Jain M, Chandel NS, Mutlu GM, Budinger GR. 2007. The intrinsic apoptotic pathway is required for lipopolysaccharide-induced lung endothelial cell death. J Immunol 179:1834-1841.
37. Ware LB, Matthay MA. 2000. The acute respiratory distress syndrome. N Engl J Med 342:1334-1349.
38. Wiel E, Pu Q, Leclerc J, Corseaux D, Bordet R, Lund N, Jude B, Vallet B. 2004. Effects of the angiotensin-converting enzyme inhibitor perindopril on endothelial injury and hemostasis in rabbit endotoxic shock. Intensive Care Med 30:1652-1659.
39. Wort SJ, Evans TW. 1999. The role of the endothelium in modulating vascular control in sepsis and related conditions. Br Med Bull 55:30-48.
40. Xu J, Qu J, Cao L, Sai Y, Chen C, He L, Yu L. 2008. Mesenchymal stem cell-based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysaccharide in mice. J Pathol 214:472-481.
41. Xu J, Woods CR, Mora AL, Joodi R, Brigham KL, Iyer S, Rojas M. 2007. Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice. Am J Physiol Lung Cell Mol Physiol 293:L131-L141.
42. Zhang H, Sun GY. 2005. LPS induces permeability injury in lung microvascular endothelium via AT(1) receptor. Arch Biochem Biophys 441:75-83.
43. Zhao YD, Courtman DW, Deng Y, Kugathasan L, Zhang Q, Stewart DJ. 2005. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease. Circ Res 96:442-450.
44. Zhao YD, Ohkawara H, Rehman J, Wary KK, Vogel SM, Minshall RD, Zhao YY, Malik AB. 2009. Bone marrow progenitor cells induce endothelial adherens junction integrity by sphingosine-1-phosphate-mediated Rac1 and Cdc42 signaling. Circ Res 105:696-704.